Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects
Abstract Dyslipidemia is an independent risk factor of cardiovascular diseases (CVDs), which lead to the high mortality, disability, and medical expenses in the worldwide. Based on the previous researches, the improvement of dyslipidemia could efficiently prevent the occurrence and progress of cardi...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-09-01
|
| Series: | Chinese Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13020-022-00666-9 |
| _version_ | 1811236464792436736 |
|---|---|
| author | Ying Hu Xingjuan Chen Mu Hu Dongwei Zhang Shuo Yuan Ping Li Ling Feng |
| author_facet | Ying Hu Xingjuan Chen Mu Hu Dongwei Zhang Shuo Yuan Ping Li Ling Feng |
| author_sort | Ying Hu |
| collection | DOAJ |
| description | Abstract Dyslipidemia is an independent risk factor of cardiovascular diseases (CVDs), which lead to the high mortality, disability, and medical expenses in the worldwide. Based on the previous researches, the improvement of dyslipidemia could efficiently prevent the occurrence and progress of cardiovascular diseases. Medicinal and edible plants (MEPs) are the characteristics of Chinese medicine, and could be employed for the disease treatment and health care mostly due to their homology of medicine and food. Compared to the lipid-lowering drugs with many adverse effects, such as rhabdomyolysis and impaired liver function, MEPs exhibit the great potential in the treatment of dyslipidemia with high efficiency, good tolerance and commercial value. In this review, we would like to introduce 20 kinds of MEPs with lipid-lowering effect in the following aspects, including the source, function, active component, target and underlying mechanism, which may provide inspiration for the development of new prescription, functional food and complementary therapy for dyslipidemia. |
| first_indexed | 2024-04-12T12:09:11Z |
| format | Article |
| id | doaj.art-80bebb53bdc24b43a166790bd0f57a01 |
| institution | Directory Open Access Journal |
| issn | 1749-8546 |
| language | English |
| last_indexed | 2024-04-12T12:09:11Z |
| publishDate | 2022-09-01 |
| publisher | BMC |
| record_format | Article |
| series | Chinese Medicine |
| spelling | doaj.art-80bebb53bdc24b43a166790bd0f57a012022-12-22T03:33:38ZengBMCChinese Medicine1749-85462022-09-0117112810.1186/s13020-022-00666-9Medicinal and edible plants in the treatment of dyslipidemia: advances and prospectsYing Hu0Xingjuan Chen1Mu Hu2Dongwei Zhang3Shuo Yuan4Ping Li5Ling Feng6China Academy of Chinese Medical Sciences Guang’anmen HospitalChina Academy of Chinese Medical Sciences Guang’anmen HospitalChina Academy of Chinese Medical Sciences Guang’anmen HospitalThe First Affiliated Hospital of Zhengzhou UniversityHenan Key Laboratory of Children’s Genetics and Metabolic Diseases, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s HospitalBeijing University of Chinese MedicineChina Academy of Chinese Medical Sciences Guang’anmen HospitalAbstract Dyslipidemia is an independent risk factor of cardiovascular diseases (CVDs), which lead to the high mortality, disability, and medical expenses in the worldwide. Based on the previous researches, the improvement of dyslipidemia could efficiently prevent the occurrence and progress of cardiovascular diseases. Medicinal and edible plants (MEPs) are the characteristics of Chinese medicine, and could be employed for the disease treatment and health care mostly due to their homology of medicine and food. Compared to the lipid-lowering drugs with many adverse effects, such as rhabdomyolysis and impaired liver function, MEPs exhibit the great potential in the treatment of dyslipidemia with high efficiency, good tolerance and commercial value. In this review, we would like to introduce 20 kinds of MEPs with lipid-lowering effect in the following aspects, including the source, function, active component, target and underlying mechanism, which may provide inspiration for the development of new prescription, functional food and complementary therapy for dyslipidemia.https://doi.org/10.1186/s13020-022-00666-9Medicinal and edible plantsDyslipidemiaLipid-loweringSignaling pathway |
| spellingShingle | Ying Hu Xingjuan Chen Mu Hu Dongwei Zhang Shuo Yuan Ping Li Ling Feng Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects Chinese Medicine Medicinal and edible plants Dyslipidemia Lipid-lowering Signaling pathway |
| title | Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects |
| title_full | Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects |
| title_fullStr | Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects |
| title_full_unstemmed | Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects |
| title_short | Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects |
| title_sort | medicinal and edible plants in the treatment of dyslipidemia advances and prospects |
| topic | Medicinal and edible plants Dyslipidemia Lipid-lowering Signaling pathway |
| url | https://doi.org/10.1186/s13020-022-00666-9 |
| work_keys_str_mv | AT yinghu medicinalandedibleplantsinthetreatmentofdyslipidemiaadvancesandprospects AT xingjuanchen medicinalandedibleplantsinthetreatmentofdyslipidemiaadvancesandprospects AT muhu medicinalandedibleplantsinthetreatmentofdyslipidemiaadvancesandprospects AT dongweizhang medicinalandedibleplantsinthetreatmentofdyslipidemiaadvancesandprospects AT shuoyuan medicinalandedibleplantsinthetreatmentofdyslipidemiaadvancesandprospects AT pingli medicinalandedibleplantsinthetreatmentofdyslipidemiaadvancesandprospects AT lingfeng medicinalandedibleplantsinthetreatmentofdyslipidemiaadvancesandprospects |